Singapore, March 22 -- Danish pharma firm Novo Nordisk has announced that it would invest approximately 4 billion yuan (Euro) in Tianjin for a sterile preparation expansion project and recently held a groundbreaking ceremony for the expansion project.

On the day of the event, leaders from the Danish Embassy in China and relevant commissions and bureaus of Tianjin City and Binhai New Area were invited to attend and jointly witnessed the launch of the project.

2024 is the 30th anniversary of the establishment of Novo Nordisk China. Thirty years ago, Novo Nordisk took the first step to establish roots in China in Tianjin, building a Tianjin production plant and making it one of its global strategic production bases.

In the first quarter o...